Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 1;157(4):392-398.
doi: 10.1001/jamadermatol.2020.5732.

Evaluation of Stigma Toward Individuals With Alopecia

Affiliations

Evaluation of Stigma Toward Individuals With Alopecia

Andrew Creadore et al. JAMA Dermatol. .

Abstract

Importance: Perceived stigma among patients with alopecia is associated with impaired quality of life; however, the magnitude of laypersons' stigma toward individuals with alopecia is unknown.

Objective: To determine the prevalence and magnitude of laypersons' stigma toward individuals with varying degrees of alopecia and whether stigma increases with increased severity of alopecia.

Design, setting, and participants: This was a cross-sectional study using an internet survey administered to a convenience sample of adult respondents in the US participating on the Amazon Mechanical Turk platform. Portrait images of 6 individuals without hair loss were created using artificial intelligence and stock images. Each portrait was edited to create 2 additional versions, 1 with scalp hair loss and 1 with complete hair loss, for a total of 18 images. On January 9 to 10, 2020, the survey presented each internet respondent with 1 randomly selected portrait to be used in answering a series of stigma-related questions from 3 domains: stereotypes, social distance, and disease-related myths; the third domain was presented only to respondents who believed that the individual pictured had a medical condition.

Main outcomes and measures: The main outcome was the prevalence and magnitude of stigma of laypersons toward individuals with alopecia and the percentage of laypersons who believed the individual pictured had a medical condition as recorded in survey responses.

Results: The survey was completed by 2015 respondents (99.9% completion rate) with a mean age of 37 (range, 18-78) years; 1014 (50.3%) were men; 1596 (79.2%) were White; and 1397 (69.3%) had a college or postcollege education. Endorsement of every stigma item increased as alopecia severity increased (2.4%-27.6%). Absolute change on the stereotype (0.5-0.6) and social distance scales (0.2-0.5) also increased, indicating more stigma. The percentage of respondents believing the individual pictured had a medical condition increased as alopecia severity increased (33.6%-75.7%; P < .001). Among the subgroup of respondents who were asked to rate their agreement with disease-related myths, the absolute change on the myth scale decreased as alopecia severity increased, indicating decreased stigma (-0.7 to -1.2).

Conclusions and relevance: This cross-sectional survey study found that stigmatizing attitudes of laypersons toward patients with alopecia exist across a multitude of social and professional scenarios. Stigma prevalence and magnitude vary by alopecia severity and possibly by whether alopecia is believed to be a medical condition.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Huang reported royalty payments from Pfizer for licensing of the ALTO tool; consulting fees from Concert and Pfizer; and participation in alopecia-related clinical trials conducted or supported by Aclaris, Concert, Incyte, and Lilly, all outside the submitted work. Dr Mostaghimi reported royalty payments from Pfizer for licensing of the ALTO tool; consulting fees from AbbVie, Concert, Digital Diagnostics, Pfizer, and Lilly; participation in alopecia-related clinical trials conducted or supported by Aclaris, Concert, Incyte, and Lilly; and equity in Hims and Hers, all outside the submitted work. Ms Manjaly reported a student internship award from the National Alopecia Areata Foundation. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Sample of Computer-Generated Portraits and 2 Versions With Varying Degrees of Alopecia
Figure 2.
Figure 2.. Respondents Who Negatively Endorsed Each of the Questions in the Survey
Numbers represent percentage of respondents who endorsed each particular survey item by choosing the 2 most negative ratings or desiring the most social distance from the individual pictured in the randomized portrait. Respondent data are grouped by severity of alopecia of the individual pictured. aRepresents percentage of respondents disagreeing with these statements.

Comment in

References

    1. Liu LY, King BA, Craiglow BG. Health-related quality of life (HRQoL) among patients with alopecia areata (AA): a systematic review. J Am Acad Dermatol. 2016;75(4):806-812.e3. doi:10.1016/j.jaad.2016.04.035 - DOI - PubMed
    1. Dubois M, Baumstarck-Barrau K, Gaudy-Marqueste C, et al. ; Quality of Life Group of the French Society of Dermatology . Quality of life in alopecia areata: a study of 60 cases. J Invest Dermatol. 2010;130(12):2830-2833. doi:10.1038/jid.2010.232 - DOI - PubMed
    1. Rencz F, Gulácsi L, Péntek M, Wikonkál N, Baji P, Brodszky V. Alopecia areata and health-related quality of life: a systematic review and meta-analysis. Br J Dermatol. 2016;175(3):561-571. doi:10.1111/bjd.14497 - DOI - PubMed
    1. Kacar SD, Soyucok E, Bagcioglu E, et al. . The perceived stigma in patients with alopecia and mental disorder: a comparative study. Int J Trichology. 2016;8(3):135-140. doi:10.4103/0974-7753.189005 - DOI - PMC - PubMed
    1. de Hollanda TR, Sodré CT, Brasil MA, Ramos-E-Silva M. Quality of life in alopecia areata: a case-control study. Int J Trichology. 2014;6(1):8-12. doi:10.4103/0974-7753.136748 - DOI - PMC - PubMed

Publication types